Evidence map›Paper›PMID 25295611›Full record

ArticlePloS one2014

Involvement of tumor macrophage HIFs in chemotherapy effectiveness: mathematical modeling of oxygen, pH, and glutathione.

Duan Chen, Andrey A Bobko, Amy C Gross, Randall Evans, Clay B Marsh, Valery V Khramtsov, Timothy D Eubank, Avner Friedman

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Mathematical modeling of tumor-immune cell interactions.Journal of theoretical biology · 2019
    Review
  5. Article
  6. The role of cellular reactive oxygen species in cancer chemotherapy.Journal of experimental & clinical cancer research : CR · 2018
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Duan ChenDepartment of Mathematics and Statistics, University of North Carolina at Charlotte, Charlotte, North Carolina, United States of America.
Andrey A BobkoDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Amy C GrossDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Randall EvansDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Clay B MarshDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Valery V KhramtsovDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Timothy D EubankDivision of Pulmonary, Allergy, Critical Care and Sleep Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, United States of America.
Avner FriedmanMathematical Biosciences Institute, The Ohio State University, Columbus, Ohio, United States of America; Department of Mathematics, The Ohio State University, Columbus, Ohio, United States of America.
The Ohio State University · USUniversity of North Carolina at Charlotte · US

Funding

The Mechanisms of GM-CSF Inhibition of Breast Cancer Growth and MetastasisR00CA131552 · NCI · OHIO STATE UNIVERSITY · PI EUBANK, TIMOTHY D · 2010 to 2012
$732k
Comparison of fMRI Analytic toolsR01MH067167 · NIMH · UNIVERSITY OF WISCONSIN MADISON · PI OAKES, TERRENCE R · 2002 to 2004
$677k
NCI NIH HHS 5R00CA131552NCI NIH HHS R00 CA131552NHLBI NIH HHS R01 HL067167NIMH NIH HHS R01 MH067167
6 · The paper itself

Abstract

The four variables, hypoxia, acidity, high glutathione (GSH) concentration and fast reducing rate (redox) are distinct and varied characteristics of solid tumors compared to normal tissue. These parameters are among the most significant factors underlying the metabolism and physiology of solid tumors, regardless of their type or origin. Low oxygen tension contributes to both inhibition of cancer cell proliferation and therapeutic resistance of tumors; low extracellular pH, the reverse of normal cells, mainly enhances tumor invasion; and dysregulated GSH and redox potential within cancer cells favor their proliferation. In fact, cancer cells under these microenvironmental conditions appreciably alter tumor response to cytotoxic anti-cancer treatments. Recent experiments measured the in vivo longitudinal data of these four parameters with tumor development and the corresponding presence and absence of tumor macrophage HIF-1α or HIF-2α in a mouse model of breast cancer. In the current paper, we present a mathematical model-based system of (ordinary and partial) differential equations to monitor tumor growth and susceptibility to standard chemotherapy with oxygen level, pH, and intracellular GSH concentration. We first show that our model simulations agree with the corresponding experiments, and then we use our model to suggest treatments of tumors by altering these four parameters in tumor microenvironment. For example, the model qualitatively predicts that GSH depletion can raise the level of reactive oxygen species (ROS) above a toxic threshold and result in inhibition of tumor growth.

Indexed as

Models, TheoreticalAnimalsBasic Helix-Loop-Helix ProteinsBreast NeoplasmsEndothelial PAS Domain-Containing Protein 1FemaleGlutathioneHydrogen-Ion ConcentrationHypoxia-Inducible Factor 1, alpha SubunitMacrophagesMiceOxygenBasic Helix-Loop-Helix ProteinsEndothelial PAS Domain-Containing Protein 1GlutathioneHypoxia-Inducible Factor 1, alpha SubunitOxygen

Identifiers

PMID25295611
PMCPMC4189793
OpenAlexW2077630473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.